Elanco Animal Health Incorporated (NYSE: ELAN), a global leader in animal health, today released new consumer research ...

Elanco Animal Health (ELAN) has attracted renewed attention after it began the phased launch of Befrena, an anti IL 31 ...

Jeff Simmons, CEO of Elanco Animal Health, says pet care and animal protein demand remain strong globally as consumers ...

Directed by Sarah Adamson through Photoplay, the campaign is shot largely from a dog’s point of view, using an immersive ...

Elanco Animal Health has begun a phased U.S. launch of Befrena, an anti-IL-31 monoclonal antibody injection for canine allergic and atopic dermatitis, following USDA approval in December 2025 and ...

Eli Lilly and Co.’s Elanco animal health business expects to raise up to $1.45 billion in its initial public offering, the company estimates, as executives gear up for a roadshow to pitch the spinoff ...

Elanco has promoted Shiv O'Neill to general counsel. O'Neill replaces Marcela A. Kirberger, who left the company last November. Shareholder activist Ancora is calling for a shake-up of the board and ...

Elanco’s new headquarters on the west edge of downtown is scheduled to open early next year. (IBJ photo/Mickey Shuey) Ancora Holdings Inc. might be the scrappiest investment firm you’ve never heard of ...

Shares of Elanco Animal Health Incorporated ELAN are trading higher on Wednesday, following a recent announcement regarding the approval of its products, Negasunt Powder and Tanidil, which received ...

Aug 1 (Reuters) - Animal health giant Elanco (ELAN.N), opens new tab is facing a new lawsuit accusing it of monopolizing the market for some flea and tick treatments, causing pet owners to pay higher ...

INDIANAPOLIS — Elanco Animal Health announced Friday its new global headquarters will be in Indianapolis. The animal pharmaceutical company will bring a $100 million campus to the old GM stamping ...

The three drugs -- tirnovetmab, KIND-039, and KIND-032 -- all fall within the dermatology category. Tirnovetmab is farthest along in the approval process, targeting regulatory approval in 2022 with ...